Famini P, Maya MM, Melmed S (2011) Pituitary magnetic resonance imaging for sellar and parasellar masses: ten-year experience in 2598 patients. J Clin Endocrinol Metab 96:1633–1641

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lake MG, Krook LS, Cruz SV (2013) Pituitary adenomas: an overview. Am Fam Physician 88:319–327

PubMed  Google Scholar 

Daly AF, Beckers A (2020) The epidemiology of Pituitary Adenomas. Endocrinol Metab Clin North Am 49:347–355

Article  PubMed  Google Scholar 

Ezzat S, Asa SL, Couldwell WT et al (2004) The prevalence of pituitary adenomas: a systematic review. Cancer 101:613–619

Article  PubMed  Google Scholar 

Brochier S, Galland F, Kujas M et al (2010) Factors predicting relapse of nonfunctioning pituitary macroadenomas after neurosurgery: a study of 142 patients. Eur J Endocrinol 163:193–200

Article  CAS  PubMed  Google Scholar 

Kirkman MA, Jaunmuktane Z, Brandner S et al (2014) Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence. World Neurosurg 82:1224–1231

Article  PubMed  Google Scholar 

Wang EL, Qian ZR, Yamada S et al (2009) Clinicopathological characterization of TSH-producing adenomas: special reference to TSH-immunoreactive but clinically non-functioning adenomas. Endocr Pathol 20:209–220

Article  CAS  PubMed  Google Scholar 

Cooper O, Melmed S (2012) Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab 26:447

Article  CAS  PubMed  PubMed Central  Google Scholar 

Micko A, Rötzer T, Hoftberger R et al (2020) Expression of additional transcription factors is of prognostic value for aggressive behavior of pituitary adenomas. J Neurosurg 134:1139–1146

Article  PubMed  Google Scholar 

Lee JC, Pekmezci M, Lavezo JL et al (2017) Utility of Pit-1 immunostaining in distinguishing pituitary adenomas of primitive differentiation from null cell adenomas. Endocr Pathol 28:287–292

Article  CAS  PubMed  Google Scholar 

Trouillas J, Roy P, Sturm N et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123–135

Article  PubMed  Google Scholar 

Wang X, Li M, Jiang X et al (2022) Prediction of higher Ki-67 index in Pituitary Adenomas by pre- and intra-operative clinical characteristics. Brain Sci 12:1002

Article  CAS  PubMed  PubMed Central  Google Scholar 

Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of Pituitary tumors. Endocr Pathol 33:6–26

Article  CAS  PubMed  Google Scholar 

Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:521–535

Article  CAS  PubMed  Google Scholar 

Drummond J, Roncaroli F, Grossman AB, Korbonits M (2019) Clinical and pathological aspects of Silent Pituitary Adenomas. J Clin Endocrinol Metab 104:2473–2489

Article  PubMed  Google Scholar 

Molitch ME (2017) Diagnosis and treatment of Pituitary adenomas: a review. JAMA 317:516–524

Article  PubMed  Google Scholar 

Roelfsema F, Biermasz NR, Pereira AM (2012) Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis. Pituitary 15:71–83

Article  PubMed  Google Scholar 

Lu L, Wan X, Xu Y et al (2022) Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions. Diagnostics (Basel) 12.: https://doi.org/10.3390/diagnostics12040977

Hofstetter CP, Nanaszko MJ, Mubita LL et al (2012) Volumetric classification of pituitary macroadenomas predicts outcome and morbidity following endoscopic endonasal transsphenoidal surgery. Pituitary 15:450–463

Article  PubMed  Google Scholar 

Lampropoulos KI, Samonis G, Nomikos P (2013) Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: a study on 184 patients. Hormones 12:254–264

Article  PubMed  Google Scholar 

Ferreira JEA, de Mello PA, de Magalhães AV et al (2005) [Non-functioning pituitary adenomas: clinical features and immunohistochemistry]. Arq Neuropsiquiatr 63:1070–1078

Article  PubMed  Google Scholar 

Watts AK, Easwaran A, McNeill P et al (2017) Younger age is a risk factor for regrowth and recurrence of nonfunctioning pituitary macroadenomas: results from a single Australian centre. Clin Endocrinol 87:264–271

Article  Google Scholar 

Richardson TE, Shen Z-J, Kanchwala M et al (2017) Aggressive behavior in Silent Subtype III Pituitary Adenomas May depend on suppression of local Immune response: a whole transcriptome analysis. J Neuropathol Exp Neurol 76:874–882

Article  CAS  PubMed  Google Scholar 

Mete O, Gomez-Hernandez K, Kucharczyk W et al (2016) Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. Mod Pathol 29:131–142

Article  CAS  PubMed  Google Scholar